Neurologian yksikkö
Department of Neurology

Julkaisut 1992
Publications 1992

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Alhainen K. Anticholinesterase drug, Tacrine (THA), in Alzheimer's disease. Discrimination of responders and nonresponders.
2 Alhainen K et al. Alzheimerin taudin kolinerginen lääkehoito.
3 Amaral DG et al. Anatomical organization of the primate amygdaloid complex.
4 Freund T, Meskenaite V. Gamma-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex.
5 Gulyás AI et al. Calretinin is present in non-pyramidal cells of the rat hippocampus-I. A new type of neuron specifically associated with the mossy fibre system.
6 Halasy K et al. GABAergic interneurons are the major postsynaptic targets of median raphe afferents in the rat dentate gyrus.
7 Halonen T. Eksitotoksinen solukuolema ja sen ehkäisy.
8 Halonen T et al. Effect of vigabatrin on the electroencephalogram in rats.
9 Halonen T et al. Amino acid levels in cerebrospinal fluid of rats after administration of pentylenetetrazol.
10 Hartikainen P et al. Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls.
11 Hartikainen P et al. Aging and spectral analysis of EEG in normal subjects; a link to memory and CSF AChE.
12 Heinonen O et al. JC virus infection and Alzheimer's disease: Reappraisal of an in situ hybridization approach.
13 Jolkkonen J et al. Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis.
14 Jolkkonen J et al. Somatostatin-like immunoreactivity in CSF of schizophrenic patients during haloperidol treatment.
15 Jäkälä P. Modulation of attention and working memory by noradrenergic, serotonergic and cholinergic systems. An experimental neuropsychopharmacological study.
16 Jäkälä P et al. The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task.
17 Jäkälä P et al. The effects of atipamezole, an alpha-2-adrenoreceptor antagonist, on the performance of rats in a five-choice serial reaction time task.
18 Jäkälä P et al. The effects of alaproclate and p-chlorophenylalanine on cued navigation performance in rats.
19 Jäkälä P et al. Continuous alpha-2-adrenoceptor blockade by atipamezole decreases neocortical high-voltage spindle activity in rats.
20 Koivisto K et al. Population-Based Dementia Screening Program in Kuopio: The effect of education, age and sex on brief neuropsychological tests.
21 Kälviäinen R. Monotherapy with vigabatrin in newly diagnosed epileptic patients.
22 Kälviäinen R. Newly diagnosed epileptic seizure disorder in adults. A prospective follow-up study on 100 patients.
23 Lahtinen H et al. Somatostatin release in rat neocortex during gamma-hydroxybutyrate-provoked seizures: microdialysis combined with EEG recording.
24 MacDonald E, Sirviö J. Neurotoxins as tools in lesioning experiments.
25 Martinez-Guijarro FJ, Freund TF. GABAergic basal forebrain afferents innervate GABAergic interneurons in the cerebral cortex of the lizard, Podarcis hispanica.
26 Mazurkiewicz M. The effect of the enhanced GABAergic transmission on cognitive functions: An experimental study.
27 Mazurkiewicz M et al. Attenuation by the benzodiazepine receptor antagonist, ZK 93 426, of the deficit in spatial navigation induced by nucleur basalis lesions.
28 Mazurkiewicz M et al. Effects of single and repeated administration of vigabatrin on the performance of rats in a 5-choice serial reaction time task.
29 Mazurkiewicz M et al. Effects of an inhibitor of GABA-aminotransferase (gamma-vinyl-GABA) on the spatial navigation deficit induced by muscarinic blockade.
30 Mervaala E et al. Pre- and postoperative auditory event-related potentials in temporal lobe epilepsy.
31 Mervaala E et al. Vireystilan lisääntymiseen liittyvä sinuspysähdys uniapneapotilaalla.
32 Miettinen R, Freund TF. Convergence and segregation of septal and median raphe inputs onto different subsets of hippocampal inhibitory interneurons.
33 Miettinen R, Freund TF. Neuropeptide Y-containing interneurons in the hippocampus receive synaptic input from median raphe and GABAergic septal afferents.
34 Miettinen R et al. Calretinin is present in non-pyramidal cells of the rat hippocampus-II. Co-existence with other calcium binding proteins and GABA.
35 Nieminen S et al. Amygdala kindling increased fear-response but did not impair spatial memory in rats.
36 Riekkinen M et al. Effects of combined methysergide and mecamylamine/scopolamine treatment on spatial navigation.
37 Riekkinen P. The ideal drug for epilepsy.
38 Riekkinen P Jr et al. Effects of tetrahydroaminoacridine on spatial navigation of nucleus-basalis- and frontal-cortex-lesioned rats.
39 Riekkinen P Jr et al. Loss of cholinergic neurons in the nucleus basalis induces neocortical electroencephalographic and passive avoidance deficits.
40 Riekkinen P Jr et al. Neurophysiological consequences of combined cholinergic and noradrenergic lesions.
41 Riekkinen P Jr et al. Effects of concurrent nicotinic antagonist and PCPA treatments on spatial and passive avoidance learning.
42 Riekkinen P Jr et al. DSP-4, a noradrenergic neurotoxin, produces more severe biochemical and functional deficits in aged than young rats.
43 Riekkinen P Jr et al. Effects of noradrenergic DSP4 lesion on the effectivenes of pilocarpine in reversing scopolamine-induced amnesia.
44 Riekkinen P Jr et al. Atipamezole an alpha-2-antagonist, stabilizes age-related high-voltage spindle and passive avoidance defects.
45 Riekkinen PJ et al. The role of the noradrenergic system in higher cerebral functions: Experimental studies about the effects of noradrenergic modulation on electrophysiology and behavior.
46 Rissanen A. Cerebrovascular disease in the Jyväskylä region, Central Finland.
47 Sirviö J et al. D-cycloserine, a modulator of the N-methyl-D-aspartate receptor, improves spatial learning in rats treated with muscarinic antagonist.
48 Sirviö J et al. Comparative effects of alpha-2 receptor agents and THA on the performance of adult and aged rats in the delayed non-matching to position task.
49 Sirviö J et al. The effects of dexmedetomidine, an alpha-2 agonist, on learning and memory, assessed using passive avoidance and water maze task in rats.
50 Sirviö J et al. The effects of alpha-2 adrenoceptor antagonist, atipamezole, on spatial learning in scopolamine-treated rats.
51 Sirviö J, Riekkinen PJ. Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies.
52 Sivenius J. Principles for the use of vigabatrin therapy in adult epilepsy.
53 Sivenius J et al. European Stroke Prevention Study: Effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke.
54 Soininen H et al. Extrapyramidal signs in Alzheimer's disease: 3-year follow-up study.
55 Soininen H et al. Diabetes mellitus and brain atrophy: A computed tomography study in an elderly population.
56 Soininen H et al. Slowing of the dominant occipital rhythm in electroencephalogram is associated with low concentration of noradrenaline in the thalamus in patients with Alzheimer's disease.
57 Soininen H et al. Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease.
58 Soininen H, Riekkinen PJ. EEG in diagnostics and follow-up of Alzheimer's disease.
59 Soininen H et al. Amyloid beta-protein deposition in skin of patients with dementia.
60 Stenafacci L et al. Projections from the lateral nucleus to the basal nucleus of the amygdala: A light and electron microscopic PHA-L study in the rat.
61 Viinamäki H et al. Prevalence of psychiatric morbidity in accident & emergency department in relation to diagnostic categories.
62 Yavich LB et al. Fast cyclic voltammetry of oxidizable species; depth profile in the rat striatum with and without potassium stimulation of the median forebrain bundle.
63 Ylinen A. Effects of vigabatrin in experimental models of epilepsy.
64 Ylinen A et al. Gamma-vinyl GABA (Vigabatrin) in epilepsy: clinical, neurochemical and neurophysiological monitoring in epileptic patients.
65 Äikiä M et al. Cognitive effects of oxcarbamazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008